{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/622b8f5080a3a00013890f23/664bd67f5c087300126eb0a2?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Tuesday, May 21, 2024","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/622b8f5080a3a00013890f23/1716246089131-05b32c410d4a32789f2e6c2d1575f742.jpeg?height=200","description":"<p>A federal transparency rule on direct-to-consumer prescription drug advertising takes effect.&nbsp;Telehealth company Hims &amp; Hers Health announced it will offer compounded GLP-1 medications.&nbsp;And the Centers for Disease Control and Preventions ends its free COVID vaccine program for the under and uninsured this summer.&nbsp;That’s coming up on today’s episode of Gist Healthcare Daily.&nbsp;</p>","author_name":"Gist Healthcare Daily"}